2026 Miners NG, GMGMF, PNPNF, AMLM: Dual-Listed Stocks Compound the Opportunity
September 4 2026 — With spot gold trading near $4,475 per ounce, investor attention continues shifting toward mining, critical-mineral and advanced-material companies whose projects may provide leveraged exposure to rising…
AI’s Next Frontier: HIVE, ANY, KEEL, CHPT Investment BOOM!
As artificial intelligence moves from experimentation toward large-scale deployment, investor attention is expanding beyond software developers and semiconductor leaders to the physical infrastructure required to keep the digital economy running.…
Catalysts Emerge BIAF, LIDR, SSM, GMGMF to Watch Now
Emerging-growth stocks bioAffinity Technologies, Inc. (NASDAQ: BIAF), AEye, Inc. (NASDAQ: LIDR), Sono Group N.V. (NASDAQ: SSM), and Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) are in focus following developments…
Microcaps GPRO, FLYE, HKPD, VIVS to Watch Now
NEW YORK, September 1, 2026 — Micro-cap and emerging-growth stocks GoPro, Inc. (NASDAQ: GPRO), Fly-E Group, Inc. (NASDAQ: FLYE), Cellyan Biotechnology Co., Ltd. (NASDAQ: HKPD) and VivoSim Labs, Inc. (NASDAQ:…
Emerging Growth WETO, AEHL, NCRA, ANY Stocks to Watch Now
Aug. 31, 2026 Emerging-growth companies spanning Physical AI, wearable robotics, livestreaming e-commerce, AI infrastructure, data centers, GPU computing and digital assets are drawing investor attention as companies pursue opportunities tied…
Small-Cap Stocks RDHL, PRSO, LGPS, WBUY Watch Now!
Aug. 31, 2026 — Several small-cap stocks are drawing investor attention following new corporate developments spanning biotechnology, military robotics, real estate and AI-enabled travel, with RedHill Biopharma Ltd. (NASDAQ: RDHL),…
IGC Pharma (NYSE: IGC) Target Raised on Alzheimer’s 2027 Outlook
POTOMAC, Md. – August 31, 2026 – IGC Pharma, Inc. (NYSE: IGC) is gaining attention after Ascendiant Capital Markets raised its 12-month price target to $6.00 from $5.50 while maintaining…
VivoSim Labs (NASDAQ: VIVS): 10,000 Compounds to 1 Drug with AI-Powered 3D Human Toxicology
SAN DIEGO, Calif., August 26, 2026 — Drug discovery can begin with 5,000 to 10,000 compounds, narrow to approximately 250 entering preclinical development, around five reaching clinical trials and ultimately…
Graphene Manufacturing (TSXV: GMG) (OTCQX: GMGMF) New G FLUID™ Technology Targets AI Data Center
Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) is expanding its commercial graphene portfolio into the rapidly growing AI data center cooling and high-density computing infrastructure market with the launch…
VivoSim Labs (NASDAQ: VIVS) Research Report Highlights AI-Powered Drug Toxicity Platform, FDA NAM Momentum
August 20, 2026 — VivoSim Labs, Inc. (NASDAQ: VIVS) is drawing investor attention following an initiation-of-coverage research report highlighting the company’s NAMkind™ 3D human tissue models, AI-powered toxicology analytics, early…